Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBVE vs Prevnar13 in Healthy Infants
NCT03467984Phase 2Completed
- Sponsor
- LG Chem
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of LBVE013 in pneumococcal infection, sponsored by LG Chem. Started May 2018; status: completed.
02
Drugs
LBVE013
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT03467984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467984.